Are Hemophilia and ITP the Same Thing?

Bruising, nosebleeds, and bleeding that takes longer to stop can happen with both hemophilia and immune thrombocytopenia (ITP). But they aren’t the same condition.

ITP is an autoimmune disorder that lowers the number of platelets in the blood. Hemophilia is an inherited disorder in which the blood doesn’t have enough of a protein called clotting factor.

In this article, we’ll explore the similarities and differences between ITP and hemophilia. Understanding their respective causes, symptoms, and treatments can help in managing each condition.

How Does Blood Clotting Work?

Because ITP and hemophilia both impair blood clotting, it’s helpful to understand what blood clotting is and how it works.

When a blood vessel is damaged, platelets gather at the site and form a temporary plug. Clotting factors then work through a chain of reactions that produces fibrin, a strong protein mesh that reinforces the plug.

ITP weakens the first part of this process because platelet counts are low. Hemophilia weakens the second part because certain clotting factors are low or don’t work properly.

ITP vs. Hemophilia: An Overview

ITP and hemophilia both interfere with the body’s blood-clotting process, but in different ways.

This means the pattern of bleeding, tests used to diagnose it, and treatment will differ.

What Causes ITP and Hemophilia?

Although the two conditions can look similar, their underlying causes are very different.

ITP Is Usually an Autoimmune Condition

In ITP, the immune system mistakenly removes platelets from the blood and may also reduce platelet production. Primary ITP has no identified underlying condition, while secondary ITP is linked to another health issue, such as an autoimmune disease, blood cancer, or infection.

Children can develop short-term ITP after an infection, while ITP in adults is more likely to last. ITP itself is not usually inherited.

Hemophilia Is Usually Inherited

Hemophilia A results from low or faulty factor VIII (8), and hemophilia B results from low or faulty factor IX (9). Most cases are caused by a gene change on the X chromosome.

This pattern of inheritance means it’s much more common in people assigned male at birth, according to Cleveland Clinic. People assigned female at birth who carry a mutation also can have low factor levels and bleeding symptoms.

How Common Are ITP and Hemophilia?

Both conditions are considered rare. In the United States, about 3 in 100,000 adults and 4 in 100,000 children are newly diagnosed with ITP each year. It can occur at any age and in people of any sex, with rates rising among older adults.

Hemophilia A affects about 12 per 100,000 males and hemophilia B affects about 3.7 per 100,000 males, according to the journal Haemophilia. This is a total of 15.7 per 100,000 males with either type.

It’s estimated that there are 30,000 to 33,000 males in the U.S. currently living with hemophilia.

ITP vs. Hemophilia Symptoms: Which Overlap and Which Differ?

As bleeding disorders that affect clotting, ITP and hemophilia share several signs and symptoms, including:

• Unexplained or excessive bleeding — This may include spontaneous nosebleeds or bloody gums during a simple dental procedure.
• Easy bruising
• Heavy menstrual periods
• Hard-to-stop bleeding
• Blood in the urine or stool

Bleeding in the brain is a very rare but potentially life-threatening complication of both conditions. It’s characterized by symptoms like persistent headaches, repeated vomiting, convulsions or seizures, or extreme sleepiness. If you experience these symptoms, seek emergency care.

How Bruising Differs in ITP vs. Hemophilia

As noted above, bruising is a common symptom in both ITP and hemophilia, but the bruises tend to have different characteristics.

ITP bruising tends to involve the skin and mucous membranes, such as those in the mouth and nose. Petechiae resemble purple, red, or brown dots — depending on skin tone — or a rash, and they are more common in ITP. People with ITP also sometimes develop purpura, larger bruises that may be red, purple, or brown, depending on skin tone.

People with hemophilia are more likely to develop many large, deep bruises following minor bumps or injuries.

People with moderate or severe hemophilia may experience bleeding inside muscles or joints, especially the knees, ankles, or elbows. A joint bleed may cause pain, warmth, swelling, or difficulty moving the joint.

How Are ITP and Hemophilia Diagnosed?

In diagnosing both conditions, a doctor will review your medical history and ask about symptoms and family history of bleeding disorders. During a physical exam, they’ll check for symptoms like pain, bleeding on or beneath the skin, and swelling associated with joint bleeds.

A complete blood count (CBC) can show whether your platelet count is low, which can be a sign of ITP and isn’t typical of hemophilia.

A peripheral blood smear allows a specialist to examine the blood cells under a microscope. It can confirm a low platelet count or may reveal platelet clumping or abnormal blood cells.

Hemophilia testing focuses on how long blood takes to clot and how much factor VIII or IX is present.

A clotting-factor test can confirm the type and severity of hemophilia by establishing how much of each clotting factor a person has in their blood. A partial thromboplastin time (PTT) test measures how quickly a person’s blood clots.

Genetic testing may identify the gene change causing hemophilia and show whether a person is a genetic carrier for hemophilia.

How Do ITP and Hemophilia Treatments Differ?

Given that ITP and hemophilia have different underlying causes, they have significantly different treatments. ITP treatment tends to focus on increasing platelet counts, whereas hemophilia treatments work to make up for clotting factor issues.

Treatments for ITP

People with mild ITP may not need treatment at all, beyond regular platelet checks. Children living with ITP often improve without any kind of treatment.

Adults may need treatment when bleeding is significant, platelet counts are very low, or other health factors increase the risk of bleeding.

If a person living with ITP does require treatment, a doctor may prescribe medications such as:

• Fast-acting treatments — Corticosteroids and IV immunoglobulin may raise platelets relatively quickly.
• Platelet-production treatments — Thrombopoietin receptor agonists help the bone marrow make more platelets.
• Immune-targeting treatments — Newer kinase inhibitors reduce the immune response that is reducing platelets. In 2025, the U.S. Food and Drug Administration (FDA) approved rilzabrutinib, the first Bruton’s tyrosine kinase (BTK) inhibitor for adults with persistent or chronic ITP who had an insufficient response to previous treatment.

In some cases, a doctor may recommend a splenectomy (surgery to remove the spleen). The spleen removes many antibody-coated platelets from circulation, so removing it may raise platelet counts. However, splenectomy can increase the risk of certain infections.

Platelet transfusions are generally reserved for emergencies involving serious or life-threatening bleeding because the immune system may quickly destroy the donated platelets.

Treatments for Hemophilia

Hemophilia treatment depends on the type and severity of the condition, a person’s age, and whether they have developed inhibitors. Inhibitors are antibodies that prevent replacement clotting factors from working properly.

Hemophilia treatment options include:

• Clotting factor replacement — These treatments may be given regularly to prevent bleeding or after bleeding begins.
• Desmopressin — This hormone may help some people with mild hemophilia A release more factor VIII. It may be given slowly into a vein or used as a nasal spray.
• Nonfactor preventive therapies — These help prevent bleeding without replacing clotting factors.
• Clot-preserving medicines — Antifibrinolytics help keep clots from breaking down. They may be used for mouth bleeding, surgery, or dental work.
• Gene therapy — The FDA has approved single-infusion gene therapies for certain adults with severe hemophilia A and certain adults with hemophilia B.